Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions
NCT00778713
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Sponsor
Ranbaxy Laboratories Limited